Flores SA - Search Results

1

Safety and Immunogenicity of V114 in Preterm Infants: A Pooled Analysis of Four Phase Three Studies.

Chapman TJ, Patel SM, Flores SA, Xu S, Lupinacci R, Shi Y, Shekar T, Feemster K, Yi J, Tamms G, Kaminski J, Bickham K, Musey L, Buchwald UK, Banniettis N. Chapman TJ, et al. Among authors: flores sa. Pediatr Infect Dis J. 2023 Nov 1;42(11):1021-1028. doi: 10.1097/INF.0000000000004069. Epub 2023 Aug 10. Pediatr Infect Dis J. 2023. PMID: 37566897 Free PMC article.

2

A Phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 compared with PCV13 in healthy infants (PNEU-PED-EU-1).

Martinon-Torres F, Wysocki J, Szenborn L, Carmona-Martinez A, Poder A, Dagan R, Richmond P, Gilbert C, Trudel MC, Flores S, Lupinacci R, McFetridge R, Wiedmann RT, Chen Q, Gerrits H, Banniettis N, Musey L, Bickham K, Kaminski J; V114-025 PNEU-PED-EU-1 study group. Martinon-Torres F, et al. Vaccine. 2023 May 16;41(21):3387-3398. doi: 10.1016/j.vaccine.2023.04.036. Epub 2023 Apr 25. Vaccine. 2023. PMID: 37105892 Free article. Clinical Trial.

3

Lot-to-lot Consistency, Safety, Tolerability and Immunogenicity of an Investigational Hexavalent Vaccine in US Infants.

Block SL, Klein NP, Sarpong K, Russell S, Fling J, Petrecz M, Flores S, Xu J, Liu G, Stek JE, Foglia G, Lee AW. Block SL, et al. Pediatr Infect Dis J. 2017 Feb;36(2):202-208. doi: 10.1097/INF.0000000000001405. Pediatr Infect Dis J. 2017. PMID: 27846058 Clinical Trial.

4

A Phase III Randomized, Double-blind, Clinical Trial of an Investigational Hexavalent Vaccine Given at Two, Three, Four and Twelve Months.

Vesikari T, Becker T, Vertruyen AF, Poschet K, Flores SA, Pagnoni MF, Xu J, Liu GF, Stek JE, Boisnard F, Thomas S, Ziani E, Lee AW. Vesikari T, et al. Among authors: flores sa. Pediatr Infect Dis J. 2017 Feb;36(2):209-215. doi: 10.1097/INF.0000000000001406. Pediatr Infect Dis J. 2017. PMID: 27846055 Clinical Trial.

5

Immunogenicity, Safety, and Tolerability of a Hexavalent Vaccine in Infants.

Marshall GS, Adams GL, Leonardi ML, Petrecz M, Flores SA, Ngai AL, Xu J, Liu G, Stek JE, Foglia G, Lee AW. Marshall GS, et al. Among authors: flores sa. Pediatrics. 2015 Aug;136(2):e323-32. doi: 10.1542/peds.2014-4102. Pediatrics. 2015. PMID: 26216331 Clinical Trial.

6

Design of a Phase III immunogenicity and safety study evaluating two-dose regimens of 9-valent human papillomavirus (9vHPV) vaccine with extended dosing intervals.

Teppler H, Bautista O; Thomas Group; Flores S, McCauley J, Luxembourg A. Teppler H, et al. Contemp Clin Trials. 2021 Jun;105:106403. doi: 10.1016/j.cct.2021.106403. Epub 2021 Apr 12. Contemp Clin Trials. 2021. PMID: 33857679

7

A Phase III randomized, double-blind, clinical trial of an investigational hexavalent vaccine given at 2, 4, and 11-12 months.

Silfverdal SA, Icardi G, Vesikari T, Flores SA, Pagnoni MF, Xu J, Liu GF, Stek JE, Boisnard F, Thomas S, Ziani E, Lee AW. Silfverdal SA, et al. Among authors: flores sa. Vaccine. 2016 Jul 19;34(33):3810-6. doi: 10.1016/j.vaccine.2016.05.054. Epub 2016 Jun 18. Vaccine. 2016. PMID: 27288217 Clinical Trial.

8

A randomized, multicenter, open-label clinical trial to assess the anamnestic immune response 4 to 8 years after a primary hepatitis B vaccination series.

Diez-Domingo J, Flores SA, Martin JC, Klopfer SO, Schödel FP, Bhuyan PK. Diez-Domingo J, et al. Among authors: flores sa. Pediatr Infect Dis J. 2010 Oct;29(10):972-4. doi: 10.1097/INF.0b013e3181f1b3b6. Pediatr Infect Dis J. 2010. PMID: 20724955 Clinical Trial.

9

Rebound Hyperthermia in Exertional Heat Stroke.

DeHan PJ, Flores SA, Rhodehouse BB, Kaplan JJ, DeGroot DW. DeHan PJ, et al. Among authors: flores sa. Mil Med. 2024 Aug 30:usae393. doi: 10.1093/milmed/usae393. Online ahead of print. Mil Med. 2024. PMID: 39212949

10

Polio, public health memories and temporal dissonance of re-emerging infectious diseases in the global north.

Kasstan-Dabush B, Flores SA, Easton D, Bhatt A, Saliba V, Chantler T. Kasstan-Dabush B, et al. Among authors: flores sa. Soc Sci Med. 2024 Sep;357:117196. doi: 10.1016/j.socscimed.2024.117196. Epub 2024 Aug 10. Soc Sci Med. 2024. PMID: 39180777 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters